Aier Eye (China) Today
| 300015 Stock | 14.44 0.32 2.27% |
Performance11 of 100
| Odds Of DistressLess than 1
|
Aier Eye is trading at 14.44 as of the 28th of November 2024, a 2.27% increase since the beginning of the trading day. The stock's open price was 14.12. Aier Eye has a very small chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Equity ratings for Aier Eye Hospital are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 30th of October 2009 | Category Healthcare | Classification Health Care |
Aier Eye is entity of China. It is traded as Stock on SHE exchange. The company has 9.33 B outstanding shares. More on Aier Eye Hospital
Moving together with Aier Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Aier Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Aier Eye's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aier Eye or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Health Management (View all Themes) | ||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, Health Management, Health Care, Health Care Providers & Services, Health Care Equipment & Services, Health Care (View all Sectors) | ||||
Aier Eye's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Aier Eye's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsAier Eye can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aier Eye's financial leverage. It provides some insight into what part of Aier Eye's total assets is financed by creditors.
| |||||
Aier Eye Hospital (300015) is traded on Shenzhen Stock Exchange in China and employs 36,718 people. Aier Eye is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 130.58 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aier Eye's market, we take the total number of its shares issued and multiply it by Aier Eye's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aier Eye Hospital operates under Health Care Providers & Services sector and is part of Health Care industry. The entity has 9.33 B outstanding shares.
Aier Eye generates positive cash flow from operations, but has no cash available
Check Aier Eye Probability Of Bankruptcy
Ownership AllocationAier Eye holds a total of 9.33 Billion outstanding shares. Aier Eye Hospital retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aier Ownership Details
Aier Eye Hospital Risk Profiles
Although Aier Eye's alpha and beta are two of the key measurements used to evaluate Aier Eye's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.49 | |||
| Semi Deviation | 4.02 | |||
| Standard Deviation | 5.56 | |||
| Variance | 30.94 |
Aier Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aier Eye without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
Aier Eye Corporate Management
Elected by the shareholders, the Aier Eye's board of directors comprises two types of representatives: Aier Eye inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aier. The board's role is to monitor Aier Eye's management team and ensure that shareholders' interests are well served. Aier Eye's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aier Eye's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Zhong Han | Deputy Director | Profile | |
| Yuanyuan Liu | Deputy CFO | Profile | |
| Li Wang | Deputy Manager | Profile | |
| Shi Wu | Secretary GM | Profile | |
| Yan Zhang | Deputy Manager | Profile | |
| Shibo Tang | Deputy Manager | Profile |
Other Information on Investing in Aier Stock
Aier Eye financial ratios help investors to determine whether Aier Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aier with respect to the benefits of owning Aier Eye security.